An evaluation of nicotinyl salicylic acid in arteriosclerosis obliterans.
D001162:Arteriosclerosis Obliterans / Q000628:therapy*; D006801:Humans; D009525:Niacin / Q000031:analogs & derivatives; D009539:Nicotinic Acids; D012459:Salicylates / Q000627:therapeutic use*; D020156:Salicylic Acid
D009539:Nicotinic Acids; D012459:Salicylates; D009525:Niacin; D020156:Salicylic Acid
ARTERIOSCLEROSIS OBLITERANS/therapy; NICOTINIC ACID/related compounds; SALICYLATES/therapeutic use